Martin Shkreli (/ˈʃkrɛli/; born March 17, 1983) is an American investor and businessman. He was convicted of financial crimes for which he served over...

winning bidder was Martin Shkreli, the CEO of Turing Pharmaceuticals, who paid a reported $2 million. In March 2018, following Shkreli's conviction for securities...

three years in prison. In early 2016, Martin Shkreli retained Brafman to defend him. In a 2017 jury trial, Shkreli was found guilty on two counts of securities...

fund manager Martin Shkreli and his controversial monetary inflation of toxoplasmosis-related pharmaceuticals, it was revealed that Shkreli was a silent...

price dropped around 10% after the price increase of the drug. CEO Martin Shkreli faced immense criticism for his actions. The company was previously...

Shaolin (2015), was purchased for $2 million by former hedge fund manager Martin Shkreli. Wu-Tang Clan has introduced and launched the careers of a number of...

Bloomberg Businessweek identified the buyer as hedge fund manager Martin Shkreli. On September 10, 2021 the Wu-Tang Clan broke their own record when...

Punch Martin Shkreli in the Face, Figuratively". Forbes. Archived from the original on 2 December 2016. Retrieved 3 December 2016. "Martin Shkreli responds...

folded after it was revealed that convicted pharmaceutical executive Martin Shkreli was a major investor. The band formed sometime in April 2014 only a...

program. Presentations from Retrophin, a company formerly headed by Martin Shkreli, CEO of Turing, from which Turing acquired the rights to Daraprim, suggested...